期刊
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE
卷 -, 期 -, 页码 -出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsptsci.2c00170
关键词
thioredoxin; oxidative stress; auranofin; imaging mass cytometry; pancreatic cancer
资金
- Ontario Centres of Excellence
- Larry Haughton Pancreatic Cancer Research Fund
- Princess Margaret Cancer Foundation
The study evaluated the combined inhibition of the glutathione and thioredoxin antioxidant systems in pancreatic ductal adenocarcinoma, finding that BSO potentiated the cytotoxicity of auranofin and induced lethal oxidative stress.
Pancreatic ductal adenocarcinoma is characterized by increased generation of reactive oxygen species that can cause lethal oxidative stress. Here, we evaluated the combined inhibition of the glutathione and thioredoxin antioxidant systems in preclinical models of pancreatic ductal adenocarcinoma, using buthionine sulfoximine (BSO) that targets glutathione synthesis, and auranofin that targets thioredoxin recycling. BSO potentiated the cytotoxicity of auranofin and induced lethal oxidative stress in primary pancreatic cancer cells. As assessed by the cellular thermal shift assay, auranofin engaged with thioredoxin reductase 1 in primary cells at concentrations known to induce cell death. Moreover, we used imaging mass cytometry to map the biodistribution of atomic gold in patient-derived xenografts treated with auranofin, and the drug was readily detectable throughout the epithelial and stromal compartments after treatment with a clinically relevant dose. In conclusion, combinatorial treatment with BSO and auranofin could serve as a potential therapeutic strategy in pancreatic ductal adenocarcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据